Original language | English (US) |
---|---|
Pages (from-to) | 19-21 |
Number of pages | 3 |
Journal | Nature genetics |
Volume | 22 |
Issue number | 1 |
DOIs | |
State | Published - May 1999 |
Externally published | Yes |
ASJC Scopus subject areas
- Genetics
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
An α-2-macroglobulin insertion-deletion polymorphism in alzheimer disease. / Rogaeva, Ekaterina A.; Premkumar, Smita; Grubber, Janet; Serneels, Lutgarde; Scott, William K.; Kawarai, Toshitaka; Song, Youqiang; Hill, De’Lisa M.; Abou-Donia, Suzanne M.; Martin, Eden R.; Vance, Jeffrey J.; Yu, Gang; Orlacchio, Antonio; Pei, York; Nishimura, Masaki; Supala, Agres; Roberge, Brenda; Saunders, Ann M.; Roses, Allen D.; Schmechel, Donald; Crane-Gatherum, Alison; Sorbi, Sandro; Bruni, Amalia; Small, Gary W.; Michael Conneally, P.; Haines, Jonathan L.; Van Leuven, Fred; George-Hyslop, Peter H.St; Farrer, Lindsay A.; Pericak-Vance, Margaret A.
In: Nature genetics, Vol. 22, No. 1, 05.1999, p. 19-21.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - An α-2-macroglobulin insertion-deletion polymorphism in alzheimer disease
AU - Rogaeva, Ekaterina A.
AU - Premkumar, Smita
AU - Grubber, Janet
AU - Serneels, Lutgarde
AU - Scott, William K.
AU - Kawarai, Toshitaka
AU - Song, Youqiang
AU - Hill, De’Lisa M.
AU - Abou-Donia, Suzanne M.
AU - Martin, Eden R.
AU - Vance, Jeffrey J.
AU - Yu, Gang
AU - Orlacchio, Antonio
AU - Pei, York
AU - Nishimura, Masaki
AU - Supala, Agres
AU - Roberge, Brenda
AU - Saunders, Ann M.
AU - Roses, Allen D.
AU - Schmechel, Donald
AU - Crane-Gatherum, Alison
AU - Sorbi, Sandro
AU - Bruni, Amalia
AU - Small, Gary W.
AU - Michael Conneally, P.
AU - Haines, Jonathan L.
AU - Van Leuven, Fred
AU - George-Hyslop, Peter H.St
AU - Farrer, Lindsay A.
AU - Pericak-Vance, Margaret A.
N1 - Funding Information: Supported by: federal grants AG09029 (L.A.F.), NS31153 (M.A.P.-V., J.L.H.) and AG05128 (A.D.R., A.S., D.S.); a LEAD award for excellence in Alzheimer disease (A.D.R.); a T.L. Temple award (M.A.P.-V.) and grants RG2-96044 (M.A.P.-V.) and RG2-96051 (J.L.H.) from the Alzheimer Association; the Medical Research Council of Canada, Canadian Genetic Diseases Network, Alzheimer Association of Ontario, Howard Hughes Medical Research Foundation, EJLB Foundation (P.H.St.G.-H.); FWO-Vlaanderen, NFWO-Lotto, VLAB/IWT, the 4th Framework EEC-Biotechnology program and by the Rooms-fund (F.V.L.); Peterborough Burgess Fellowship (E.A.R.); Uehara Memorial Funding Information: Foundation and Japan Society for the Promotion of Science (T.K.); and a fellowship from NIH grant T32-AG00115 (S.P.). Funding Information: We thank the clinicians and staff of the Mayo Institute and Washington University School of Medicine, NIMH and NIA. This work was supported by the Medical Research Council (UK), the Institut National pour la Santé Et la Recherche Médicale (INSERM), the Institut Pasteur de Lille, the Conseil Régional du Nord-Pas de Calais axe régional de recherche sur les maladies neurodégénératives et le vieillissement cérébral and the Fondation pour la Recherche Médicale, The Mayo Foundation, National Institute of Health, the Alzheimer’s Disease Association and the Nettie and Rebecca Brown Foundation. Copyright: Copyright 2016 Elsevier B.V., All rights reserved.
PY - 1999/5
Y1 - 1999/5
UR - http://www.scopus.com/inward/record.url?scp=84984933081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84984933081&partnerID=8YFLogxK
U2 - 10.1038/8732
DO - 10.1038/8732
M3 - Article
AN - SCOPUS:84984933081
VL - 22
SP - 19
EP - 21
JO - Nature Genetics
JF - Nature Genetics
SN - 1061-4036
IS - 1
ER -